SVA Life Sciences is proud to announce the firm will be an exhibitor at the 2022 World Orphan Drug Congress held on July 11-13,...

SVA Life Sciences is proud to announce the firm has earned the Veeva Services Partner certification for the second year in a row....

SVA Life Sciences, a division of SVA Consulting, is pleased to announce that Sara’s Cure (DBA Clear Cell Sarcoma Foundation) has...

Andrew DeMarco, SVA Life Sciences Principal and Commercialization Strategist, and Chuck Howe, member of the SVA Life Sciences...

Why Organizational Readiness Should be Priority of First-Time Launchers You’ve done groundbreaking research, developed options,...

Your biopharma company is evolving. You have increased headcount, M&A activity, clinical activity, outsourcing activities or need...

As a first-time launcher, the ability to quickly identify hurdles and take action through this exciting and turbulent time is...

Life sciences companies evolve and grow very differently than most industries. As you move through the various stages from...

One of the key learnings from successful product launches is that successful launch teams relentlessly measure performance and...

Clinical development activities generate lots of data – data that might be rich with promising information, but in reality, it’s...